Xarelto Bellwether Loser Says New Study Merits Retrial
By Daniel Siegal · September 20, 2017, 8:12 PM EDT
A woman who lost a federal bellwether trial on claims that Janssen Pharmaceuticals' and Bayer's blood thinner Xarelto caused her hospitalization for internal bleeding has moved for a new trial, arguing...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login